ADAM17 inhibition may exert a protective effect on COVID-19

dc.contributor.author Palau González, Vanesa
dc.contributor.author Riera, Marta
dc.contributor.author Soler, María José
dc.date.accessioned 2021-10-26T05:58:25Z
dc.date.available 2021-10-26T05:58:25Z
dc.date.issued 2020
dc.format.mimetype application/pdf
dc.identifier.citation Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093
dc.identifier.doi http://dx.doi.org/10.1093/ndt/gfaa093
dc.identifier.issn 0931-0509
dc.identifier.uri http://hdl.handle.net/10230/48810
dc.language.iso eng
dc.publisher Oxford University Press
dc.relation.ispartof Nephrol Dial Transplant. 2020;35(6):1071-2
dc.rights © Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology, dialysis, transplantation following peer review. The version of record Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 is available online at: http://dx.doi.org/10.1093/ndt/gfaa093
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.subject.keyword covid-19
dc.title ADAM17 inhibition may exert a protective effect on COVID-19
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/acceptedVersion

Col·leccions